Zou M X, Yu M Y, Zhang H F, Huang J Q, Chen J M
302 Hospital of PLA, Beijing.
Chin Med J (Engl). 1991 Feb;104(2):124-7.
Pre-S2 protein and its antibody were detected in 130 children with hepatitis B virus (HBV) infection and 30 with T6 hepatitis B (HB) vaccination. The results showed that pre-S2 was positive in most chronic persistent hepatitis (CPH) and chronic active hepatitis(CAH) patients, while anti-pre-S2 was positive in only 8% (2/92 cases) and 11.5% (3/26 cases) respectively. The positive rate of anti-pre-S2 was 78.9% (15/19 cases) in cases at the convalescent stage of acute hepatitis B, 91.7% (55/60 cases) in cases with T6 HB vaccination and 83.3% (25.30 cases) in naturally acquired anti-HBs children, while pre-S2 was not noted. Anti-pre-S2 was negatively related to ALT and positively to anti-HBs (P less than 0.01). The positive relation of pre-S2 to HBsAg was observed. These results suggest that pre-S2 could be a marker for HBV infection, and anti-pre-S2 may indicate a favourable prognosis of HBV infection. There was no correlation between anti-pre-S2 and pathogenic damages induced by HBV.
对130例乙型肝炎病毒(HBV)感染儿童和30例接种T6乙肝疫苗儿童检测前S2蛋白及其抗体。结果显示,大多数慢性持续性肝炎(CPH)和慢性活动性肝炎(CAH)患者前S2呈阳性,而抗前S2分别仅在8%(2/92例)和11.5%(3/26例)呈阳性。急性乙型肝炎恢复期患者抗前S2阳性率为78.9%(15/19例),接种T6乙肝疫苗者为91.7%(55/60例),自然获得抗-HBs儿童为83.3%(25/30例),而未发现前S2阳性。抗前S2与丙氨酸氨基转移酶(ALT)呈负相关,与抗-HBs呈正相关(P<0.01)。观察到前S2与乙肝表面抗原(HBsAg)呈正相关。这些结果表明,前S2可能是HBV感染的标志物,抗前S2可能提示HBV感染预后良好。抗前S2与HBV所致的致病性损害之间无相关性。